Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
5
71%
Ph phase_2
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)
Other(2)

Detailed Status

unknown2
Completed2
Terminated1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (16.7%)
N/A5 (83.3%)

Trials by Status

terminated114%
unknown229%
withdrawn114%
completed229%
not_yet_recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7